Product Liability Archive » March, 2008

Product Liability - March, 2008

143 articles

• WTO Rules EU Failed To Justify Hormone Meat Ban
• Doctors Slam Cholesterol Drugs Over Safety Concerns
• U.K. Yanks Cold Medicines Over Safety Concerns
• Ford Must Pay Widower $13M Over Faulty Fuel Tank
• K&L Gates Adds Nuclear Energy Powerhouse
• Judge Lets MS Drugmaker Off The Hook - For Now
• Recalls Of Tainted Cantaloupe Continue To Rise
• FDA Says Diabetic Foot Gel Could Cause Cancer
• Dow Chemical Leak Case Is Moved To Federal Court
• FDA Demands Safety Plans For 25 Drugs, Biologics
• HIV Drugs May Increase Risk Of Heart Attack: FDA
• FDA Seeks $2.2M For Hearing Aid Violations
• Kinks Persist In Class Action Fairness Act: Experts
• FTC, TJX Settle Retail Data Breach Cases
• FDA Proposes More Stringent Rules For Some Stents
• Developer Seeks $12B From Airlines For Sept. 11
• Victims' Families Sue Brazilian Airline Over Crash
• Barred Expert Decision Revives Suit Against Ford
• Amgen Ruling Will Increase Section 337 Investigations
• Abilify Off-Label Marketing Case Settled For $4M
• NYC Found Fully Liable For Ferry Crash
• FDA Eyes Suicide Links With Merck's Singulair
• Lilly To Hand Over $15M To Settle Alaska Zyprexa Suit
• GM Settles Class Action Over Engine Coolant
• Guidant MDL Lawyers Ask Judge To Reconsider Order
• Male-Enhancement Products Pose Health Risks: FDA
• Green Group Calls On SEC To Fine Chevron
• GM Hit With Seat Belt Suit Over Child's Death
• First Claimant In NYC Crane Accident Seeks $30M
• Critics Say Lawyer Provision Of Vioxx Deal Is Unethical
• Novartis Escapes Some Lotensin Claims
• Pfizer's Document Bid Blocked In Celebrex Case
• GE Unit Hit With $1.2M Suit Over Fire Cleanup
• Cooper Recalls Tires With Sidewall Problems
• AstraZeneca Gets Nod To Recruit Plaintiffs' Doctors
• Four More Countries Recall Heparin
• CNN Must Turn Over Stand 'N Seal Footage: Judge
• OSHA Levies $1M In Fines For Fatal Tunnel Fire
• Ciresi Steps Down As Robins Kaplan Chairman
• Pilot Sues Boeing After Fighter Fails In Flight
• Salmonella-Tainted Cantaloupes Recalled
• FDA Panel To Discuss New Drug Label Warnings
• Justices Reinforce Federal Preemption In Riegel
• Neurontin Class Action To Include Generics Buyers
• Scruggs' Son Signs Plea Agreement In Bribery Case
• China Vows Closer Oversight Of Heparin Producers
• Agency Outreach Focuses On Toxins In Packaging
• Peruvians' Toxic Tort Is Removed To State Court
• City Claims Dow, Shell Polluted Wells: Report
• Disbarment Looms For Scruggs
• Jury Awards $25M In Asbestos Case: Report
• Ford Not Liable For Rear Guard Failure: Court
• Tribal Authority Must Face Toxic-Housing Claims
• ARCO Settles Plant Neighbors' Claims For $27M
• Spiriva May Increase Stroke Risk: FDA
• Judge Questions Law In Handing Wyeth Victory
• Claimants Push For Expert In W.R. Grace Case
• FDA Finds Impurity In Suspect Heparin Batches
• FDA Warns Of High Mortality Rate For Medtronic Stent
• $1.7M Award For Injured Transocean Worker Upheld
• Corpse Harvester Cops A Plea
• FDA To Look At Efficacy Of LASIK Surgery
• $5M Workplace Exposure Award Upheld
• Amgen's Woes Worsen With Enbrel Black Box Warning
• Arnold & Porter Welcomes Partners In San Francisco
• Reebok To Pay $1M Following Bracelet Recall
• Pilot Charged With Negligence In Calif. Oil Spill
• FDA To Stop All Heparin At The Border For Testing
• Senators Offer Bill To Enforce Meat Safety Standards
• Toxic Tort Against Weyerhaeuser Gets Go-Ahead
• W.R. Grace, Feds Strike Deal Over Cleanup
• FDA Reveals Plan To Open Satellite Offices In China
• Riegel v. Medtronic: A Win For Medical Technology
• High Court Passes On Tobacco Advertising Suit
• Vioxx Deal May Become Model For Future Agreements
• U.S. Law Doesn't Trump State Claim In Paxil Suit
• The Times Are Changing At The CPSC
• Congressmen Grill Mukasey On BP Settlement
• Scruggs Enters Surprise Plea In Bribery Case
• Santa Monica, Attorneys Lay Fee Dispute To Rest
• Court Denies N.J.'s Late Claim Against W.R. Grace
• FDA Advises Virtual Ban On Amgen, J&J Anemia Drugs
• Germany Asks Cos. To Look For Tainted Heparin
• HIV Drug Potentially Tied To Liver Damage
• Under Pressure, Food Cos. Mull New Recall System
• Microsoft Seeks Time To Overturn Class On Appeal
• Recalls Raise Talk Of Mainstreaming Food Irradiation
• W.R. Grace To Pay $250M For Asbestos Cleanup
• Couple Wins $20M Asbestos Verdict
• $165M Settlement Reached In Philippines Crash
• Preemption On The Mind: Recent High Court Rulings
• FDA Gives OK To Miss Some Drug Approval Deadlines
• Three Japanese Cos. Recall Heparin Products
• Ailing Vitamin Co. Seeks Refuge In Bankruptcy
• FDA Issues Word Of Caution Over Tussionex
• Edwards LifeSciences Hit With $40M Verdict
• FDA Reappoints Former Chief Of Drug Safety Center
• Appeals Court Reaffirms $82M Award In Ford Case
• CSPC, Vietnam Agree To Closer Scrutiny Of Imports
• Dole Award Reduced For Nicaragua Banana Farmers
• Jury Spurns Welders' Claim Of Fumes-Illness Link
• Black Box Warning Strengthened On Anemia Drugs
• Sonnenschein Adds Top Pharmaceuticals Litigator
• Claims-Made Settlements In Consumer Class Actions
• Lilly's Greed Steered Course Over Zyprexa: Official
• Wyeth, Upjohn Hit With $27M In Punitive Damages
• Cessna Seat Defect Caused Crash: Passengers
• Senate Passes Consumer Product Safety Bill
• House Presses Meat Co. Exec On Recall Details
• Judge Tosses Liability Claim In Lawnmower Fire Suit
• Judge OKs Webcast Of Zyprexa Hearing
• Conn. Jumps Into Zyprexa Fray With Lawsuit
• Firm Wins $3.3M Fee In Motorola Environmental Suit
• FDA Asks GSK, Others For Data On Asthma Drugs
• Ohio's Tort-Reform Tug-Of-War
• Senate Vote Expected Soon On Consumer Safety Bill
• U.S. Officials Concede Vaccines Led To Disorder
• GSK Probe Prompts U.K. To Boost Drug Oversight
• FDA Warns Internet Sellers Of Unapproved STD Drugs
• Timing Of Recalls Poses Challenges For Medical Cos.
• Paris Court Bounces Boeing Suit To U.S.
• House Subpoenas Exec For Hearing On Beef Recall
• Supreme Court Ruling Could Impact Aredia Case
• Roche Warns Of Psychotic Reactions To Tamiflu
• Pfizer Quits Bickering Over Mirapex Bellwether Trials
• Drug Safety Concerns Prompt GAO Probe Of FDA
• Airborne Settles False-Ad Class Action For $23M
• Bellwether Case Picked For Lens Solution MDL
• Court Finds Listerine Class Bid Hard To Swallow
• FDA Unlikely To Curb Off-Label Marketing: Sources
• Allergan Faces DOJ Subpoena Over Botox
• Claims Against BP For Texas City Blast Exceed $2B
• Senate To Begin Debate On CPSC Overhaul
• Seroquel Plaintiffs Win Bid To Quiz Doctors
• Judge Tosses Suit Over Barr's Morning-After Pill
• Plaintiffs Signing On To $5B Vioxx Deal: Merck
• Bill Aims To Beef Up USDA Recall Power
• Supreme Court Deadlock Lets Rezulin Case Advance
• Punitive Damages Possible In Wyeth Hormone Trial
• CPSC Names Akin Gump Partner As General Counsel
• Options For Disputing Liability With Chinese Suppliers
• Wyeth Wins Dimissal Of Weight-Loss Drug Suit
• Eli Lilly Gears Up For Zyprexa Showdown